ArticleApplied psychophysiology and biofeedback2026
Baseline Depressive Symptoms and Heart Rate Variability Indices Predict HRV Biofeedback Outcomes in Young Adults with Depression.
Article in Applied psychophysiology and biofeedback, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart rate variability biofeedback (HRVB) has been confirmed to enhance cardiovagal activation and alleviate depressive symptoms in patients with major depressive disorder (MDD). However, it remains unknown which dimensions of depression predict better treatment outcomes following HRVB. This study utilized a randomized controlled trial design. A total of 59 patients with depressive disorder were enrolled and randomly assigned to either the HRVB group or the relaxation training (RT) group. Both groups receive 60-min training sessions twice weekly for 10 sessions over five weeks. Psychological variables (depression and anxiety) and lead II electrocardiogram (ECG) were collected at pre-test and post-test. ECG data were converted into HRV indices. Two-way mixed-design analyses of variances were conducted to examine the Group (HRVB vs. RT) × Time (pre-test vs. post-test transfer) interaction effects on psychological outcomes and HRV indices. In addition, participants in the HRVB group were classified as responders (n = 10) or non-responders (n = 14) based on change in the root mean square of successive differences between normal heartbeats (RMSSD) following HRVB. Differences in demographic and psychological variables between these subgroups were further examined. (1) Both groups showed significant reductions in depression and anxiety over time; however, no significant differences between groups were observed. (2) At the transfer stage, the HRVB group demonstrated significant increases in HRV indices from pre-test rest stage to post-test transfer stage. (3) Within the HRVB group, responders exhibited significantly lower levels of depressive symptoms (including loss of pleasure, loss of interest, worthlessness, and loss of energy) and lower parasympathetic activity compared with non-responders. HRVB not only alleviated depression and anxiety symptoms but also enhanced autonomic nervous system activity. Moreover, patients who derived the greatest benefit from HRVB tended to exhibit more favorable psychological features at pre-test. These findings may inform the development of personalized and evidence-based psychological interventions for patients with depressive disorders.
Indexed as
Identifiers
41998368What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.